FDA has also declared psilocybin a breakthrough therapy for treatment-resistant depression and just recently approved esketamine for depression.
Proglasila je i psilocibin terapijom prvog izbora za depresiju koja ne reagira na obični tretman i nedavno dozvolila esketamin za depresiju.